MicroRNAs as Prognostic Biomarkers in Prostate Cancer
Prostate cancer, one of the most common cancers among men, can be relatively harmless or extremely aggressive. The most widely used biomarker for the disease, the PSA test, is not independently diagnostic or prognostic of prostate cancer. One of the main challenges of prostate cancer research is to...
Main Author: | Gordanpour, Aida |
---|---|
Other Authors: | Seth, Arun |
Language: | en_ca |
Published: |
2012
|
Subjects: | |
Online Access: | http://hdl.handle.net/1807/34019 |
Similar Items
-
MicroRNAs as Prognostic Biomarkers in Prostate Cancer
by: Gordanpour, Aida
Published: (2012) -
MicroRNA-21 and microRNA-30c as diagnostic biomarkers for prostate cancer: a meta-analysis
by: Zhou H, et al.
Published: (2019-03-01) -
MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer
by: Valentina Doldi, et al.
Published: (2021-05-01) -
A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group
by: Brian D. Kelly, et al.
Published: (2015-07-01) -
MicroRNAs as the critical regulators of protein kinases in prostate and bladder cancers
by: Malihe Zangoue, et al.
Published: (2021-09-01)